Literature DB >> 29630420

Evaluation of Optical Quality: Ocular Scattering and Aberrations in Eyes Implanted with Diffractive Multifocal or Monofocal Intraocular Lenses.

Xuan Liao1,2, Jia Lin1,2, Jing Tian1,2, BaiWei Wen1,2, QingQing Tan1,2, ChangJun Lan1,2.   

Abstract

PURPOSE: To compare objective optical quality, ocular scattering and aberrations of eyes implanted with an aspheric monofocal intraocular lens (IOL) or an aspheric apodized diffractive multifocal IOL three months after surgery.
METHODS: Prospective consecutive nonrandomized comparative cohort study. A total of 80 eyes from 57 cataract patients were bilaterally or unilaterally implanted with monofocal (AcrySof IQ SN60WF) or multifocal (AcrySof IQ ReSTOR SN6AD1) IOLs. Respectively, 40 eyes of 27 patients were implanted with monofocal IOLs, and 40 eyes of 30 patients were implanted with multifocal IOLs. Ocular high-order aberration (HOA) values were obtained using Hartmann-Shack aberrometer; objective scatter index (OSI), modulation transfer function (MTF) cutoff, Strehl ratio (SR), and contrast visual acuity OV at 100%, 20%, and 9% were measured using Objective Quality Analysis System II (OQAS II).
RESULTS: Ocular aberrations performed similar in both groups (p > 0.05). However, significantly higher values of OSI and lower values of MTF cutoff, SR and OV were found in the SN6AD1 group (p < 0.05).
CONCLUSIONS: Both ocular scattering and wave-front aberrations play essential role in retinal image quality, which may be overestimated when only aberrations were taken into account. Combining the effect of ocular scattering with HOA will result in a more accurate assessment of the visual and optical quality.

Entities:  

Keywords:  Optical quality; cataract; intraocular lenses; monofocal; multifocal

Mesh:

Year:  2018        PMID: 29630420     DOI: 10.1080/02713683.2018.1449220

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  Bias of near-infrared light in evaluation of patients implanted with multifocal intraocular lenses.

Authors:  Francisco de Asís Bartol-Puyal; Galadriel Giménez; Silvia Méndez-Martínez; Irene Altemir; José Manuel Larrosa; Vicente Polo; Luis Pablo
Journal:  Int Ophthalmol       Date:  2021-05-25       Impact factor: 2.031

2.  Agreement between subjective and predicted high and low contrast visual acuities with a double-pass system.

Authors:  Joaquín Fernández; Manuel Rodríguez-Vallejo; Javier Martínez; Noemi Burguera; David P Piñero
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-31       Impact factor: 3.117

3.  Clinical outcomes of topography-guided femtosecond laser-assisted in situ keratomileusis after multifocal intraocular lens implantation.

Authors:  Eunhae Shin; Young-Sik Yoo; Sung-Ho Choi; Sun-Hyup Han; Dong Hui Lim; Gil-Joong Yoon; Tae-Young Chung
Journal:  Sci Rep       Date:  2020-06-30       Impact factor: 4.379

4.  Retinal-image quality and contrast sensitivity function in eyes with epiretinal membrane: a cross-sectional observational clinical study.

Authors:  Limei Liu; Yi Wang; Ju Liu; Wu Liu
Journal:  BMC Ophthalmol       Date:  2018-11-07       Impact factor: 2.209

5.  Long-Term Clinical Outcomes after Mix and Match Implantation of Two Multifocal Intraocular Lenses with Different Adds.

Authors:  Yuanfeng Jiang; Shaochong Bu; Fang Tian; Jingli Liang; Tiecheng Wang; Xiuli Xing; Hong Zhang; Xiaomin Zhang
Journal:  J Ophthalmol       Date:  2019-01-14       Impact factor: 1.909

6.  Posterior capsular opacification comparison between morphology and objective visual function.

Authors:  Chengzhe Lu; Shasha Yu; Hui Song; Yun Zhao; Shiyong Xie; Xin Tang; Xiaoyong Yuan
Journal:  BMC Ophthalmol       Date:  2019-02-04       Impact factor: 2.209

7.  Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity.

Authors:  Bo Lu; Weijie Zhu; Yu Fan; Dong Shi; Liwei Ma
Journal:  BMC Ophthalmol       Date:  2021-01-06       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.